EKF Diagnostics Holdings Plc
Research EKF Diagnostics Holdings Plc (EKF) on Bullrun: market cap GBX 10.88B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEKF
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyGBX
- Market capGBX 10.88B
- Financial periodFY2025
- RevenueGBP 51.56M
- Revenue growth2.7%
- Net incomeGBP 2.12M
- Free cash flowGBP 7.34M
- Gross margin51.4%
Valuation Snapshot
latest market cap is GBX 10.88B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 51.56M | GBP 2.12M | GBP 7.34M | 51.4% | 0 | GBP 13.69M | GBP 1.39M | GBP 69.05M |
| FY2024 | GBP 50.19M | GBP 6.24M | GBP 10.90M | 47.9% | 0.01 | GBP 13.01M | GBP 1.32M | GBP 72.33M |
| FY2023 | GBP 52.61M | GBP 2.35M | -GBP 664.00K | 45.3% | 0.01 | GBP 6.02M | GBP 4.10M | GBP 67.12M |
| FY2022 | GBP 66.64M | -GBP 10.10M | GBP 3.86M | 36.1% | -0.02 | GBP 9.21M | GBP 1.55M | GBP 73.35M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | GBX 10.88B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
| Year | Dividends/share |
|---|---|
| FY2023 | 1.2 GBP |
| FY2022 | 1.2 GBP |
| FY2021 | 1.1 GBP |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is EKF Diagnostics Holdings Plc's market cap?
EKF Diagnostics Holdings Plc's market capitalization is GBX 10.88B.
What does EKF Diagnostics Holdings Plc do?
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.